Benat Mallavia
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice.
Journal: Diabetes
Published: December 22, 2014
Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
Journal: Diabetologia
Published: November 29, 2014
Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: July 12, 2014
Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice.
Journal: Basic research in cardiology
Published: May 15, 2014
Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice.
Journal: Brain : a journal of neurology
Published: September 11, 2012
Fcγ receptor deficiency attenuates diabetic nephropathy.
Journal: Journal of the American Society of Nephrology : JASN
Published: August 04, 2012
Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis.
Journal: The American journal of pathology
Published: July 19, 2012
Renal delivery of adenovirus and antisense oligonucleotides in rats by retrograde renal vein injection.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 29, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026